Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 70% ± 25% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 40% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 28850.51 | 226 / 226 | 94% | 379.74 | 380 / 406 |
spleen | 81% | 1536.58 | 196 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 8859.33 | 748 / 929 | 0% | 0 | 0 / 0 |
skin | 70% | 3652.41 | 1271 / 1809 | 10% | 2.48 | 48 / 472 |
lung | 50% | 481.08 | 289 / 578 | 8% | 0.46 | 90 / 1155 |
esophagus | 1% | 2.84 | 9 / 1445 | 14% | 0.69 | 26 / 183 |
prostate | 1% | 4.47 | 2 / 245 | 8% | 0.30 | 42 / 502 |
adipose | 9% | 59.81 | 107 / 1204 | 0% | 0 | 0 / 0 |
brain | 0% | 0.11 | 1 / 2642 | 8% | 0.13 | 53 / 705 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.72 | 13 / 178 |
breast | 4% | 22.34 | 20 / 459 | 3% | 0.28 | 32 / 1118 |
uterus | 1% | 3.50 | 1 / 170 | 6% | 0.24 | 28 / 459 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.29 | 31 / 504 |
stomach | 1% | 6.92 | 4 / 359 | 3% | 0.10 | 8 / 286 |
intestine | 0% | 0.52 | 1 / 966 | 4% | 0.60 | 20 / 527 |
thymus | 2% | 7.32 | 12 / 653 | 2% | 0.04 | 10 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
kidney | 1% | 4.08 | 1 / 89 | 2% | 0.24 | 20 / 901 |
adrenal gland | 0% | 0 | 0 / 258 | 3% | 0.05 | 6 / 230 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
heart | 2% | 9.07 | 17 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 9.88 | 19 / 1335 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.10 | 6 / 430 |
muscle | 0% | 3.86 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070965 | Biological process | positive regulation of neutrophil mediated killing of fungus |
GO_0045087 | Biological process | innate immune response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0060336 | Biological process | negative regulation of type II interferon-mediated signaling pathway |
GO_0006527 | Biological process | arginine catabolic process |
GO_2000552 | Biological process | negative regulation of T-helper 2 cell cytokine production |
GO_0002250 | Biological process | adaptive immune response |
GO_0019547 | Biological process | arginine catabolic process to ornithine |
GO_0000050 | Biological process | urea cycle |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030145 | Molecular function | manganese ion binding |
GO_0004053 | Molecular function | arginase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ARG1 |
Protein name | Arginase 1 Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase) Arginase (EC 3.5.3.1) Arginase-1 (Liver-type arginase) (Type I arginase) |
Synonyms | |
Description | FUNCTION: Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys. .; FUNCTION: Functions in L-arginine homeostasis in nonhepatic tissues characterized by the competition between nitric oxide synthase (NOS) and arginase for the available intracellular substrate arginine. Arginine metabolism is a critical regulator of innate and adaptive immune responses. Involved in an antimicrobial effector pathway in polymorphonuclear granulocytes (PMN). Upon PMN cell death is liberated from the phagolysosome and depletes arginine in the microenvironment leading to suppressed T cell and natural killer (NK) cell proliferation and cytokine secretion . In group 2 innate lymphoid cells (ILC2s) promotes acute type 2 inflammation in the lung and is involved in optimal ILC2 proliferation but not survival (By similarity). In humans, the immunological role in the monocytic/macrophage/dendritic cell (DC) lineage is unsure. . |
Accessions | ENST00000368087.8 [P05089-1] ENST00000673427.1 P05089 A0A5F9ZGY6 ENST00000672233.1 A0A5F9ZH78 ENST00000673234.1 ENST00000356962.2 [P05089-2] A0A5F9ZGN6 |